Literature DB >> 25083496

Stem cell and tissue engineering in breast reconstruction.

Tanasit Techanukul1, Visnu Lohsiriwat1.   

Abstract

Breast cancer worldwide is the most common cancer in women with incidence rate varying from geographic areas. Guidelines for management of breast cancer have been largely established and widely used. Mastectomy is one of the surgical procedures used treating breast cancer. Optionally, after mastectomy, appropriately selected patients could undergo breast reconstruction to create their breast contour. Many techniques have been used for breast reconstructive surgery, mainly implant-based and autologous tissue reconstruction. Even with highly-experienced surgeon and good-quality breast and autologous substitute tissue, still there could be unfilled defect after mastectomy with reconstruction. Stem cell, in particular, adipose-derived stem cell residing within fat tissue, could be used to fill the imperfection providing optimal breast shape and natural feeling of fat tissue. However, whether surgical reconstruction alone or in combination with stem cell and tissue engineering approach be used, the ultimate outcomes are patient safety first and satisfaction second.

Entities:  

Keywords:  Stem cell; adipose-derived stem cell; breast reconstruction; tissue engineering

Year:  2014        PMID: 25083496      PMCID: PMC4115774          DOI: 10.3978/j.issn.2227-684X.2014.02.11

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  64 in total

1.  Evidence for stem cells in the peripheral blood of mice.

Authors:  J W GOODMAN; G S HODGSON
Journal:  Blood       Date:  1962-06       Impact factor: 22.113

2.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

Review 3.  Stem cell states, fates, and the rules of attraction.

Authors:  Tariq Enver; Martin Pera; Carsten Peterson; Peter W Andrews
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

4.  Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching.

Authors:  H J Meuwissen; R A Gatti; P I Terasaki; R Hong; R A Good
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

Review 5.  The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.

Authors:  Danny R Youlden; Susanna M Cramb; Nathan A M Dunn; Jennifer M Muller; Christopher M Pyke; Peter D Baade
Journal:  Cancer Epidemiol       Date:  2012-03-27       Impact factor: 2.984

6.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

7.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

8.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

9.  Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.

Authors:  André Tomescot; Julia Leschik; Valérie Bellamy; Gilbert Dubois; Emmanuel Messas; Patrick Bruneval; Michel Desnos; Albert A Hagège; Michal Amit; Joseph Itskovitz; Philippe Menasché; Michel Pucéat
Journal:  Stem Cells       Date:  2007-05-31       Impact factor: 6.277

10.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.

Authors:  Kosuke Yusa; S Tamir Rashid; Helene Strick-Marchand; Ignacio Varela; Pei-Qi Liu; David E Paschon; Elena Miranda; Adriana Ordóñez; Nicholas R F Hannan; Foad J Rouhani; Sylvie Darche; Graeme Alexander; Stefan J Marciniak; Noemi Fusaki; Mamoru Hasegawa; Michael C Holmes; James P Di Santo; David A Lomas; Allan Bradley; Ludovic Vallier
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

View more
  2 in total

1.  Isolation and characterization of adult mammary stem cells from breast cancer-adjacent tissues.

Authors:  Ai-Ping Shi; Zhi-Min Fan; Ke-Wei Ma; Yan-Fang Jiang; Lei Wang; Ke-Wei Zhang; Shi-Bo Fu; Ning Xu; Zhi-Ru Zhang
Journal:  Oncol Lett       Date:  2017-06-28       Impact factor: 2.967

2.  Epigenetic drugs induce the potency of classic chemotherapy, suppress post-treatment re-growth of breast cancer, but preserve the wound healing ability of stem cells.

Authors:  Andrew Zheng; Michelle Bilbao; Janhvi Sookram; Kimberly M Linden; Andrew B Morgan; Olga Ostrovsky
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.